Net Cash Provided by (Used in) Operating Activities |
70M |
USD |
-93.5% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Financing Activities |
18.3B |
USD |
+59.2% |
Mar 31, 2024 |
Q1 2024 |
Net Cash Provided by (Used in) Investing Activities |
-16.4B |
USD |
-191% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares Authorized |
90B |
shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Shares, Issued |
569M |
shares |
+0.28% |
Mar 31, 2024 |
Q1 2024 |
Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
2.03B |
USD |
-70.9% |
Mar 31, 2024 |
Q1 2024 |
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
19.7B |
USD |
+9.02% |
Mar 31, 2024 |
Q1 2024 |
Interest Paid, Excluding Capitalized Interest, Operating Activities |
167M |
USD |
-1.18% |
Mar 31, 2024 |
Q1 2024 |
Deferred Tax Assets, Valuation Allowance |
33M |
USD |
-68.6% |
Dec 31, 2023 |
Q4 2023 |
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
0% |
Dec 31, 2023 |
Q4 2023 |
Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
5.98B |
USD |
-37.6% |
Mar 31, 2024 |
Q1 2024 |
Deferred Income Tax Expense (Benefit) |
-1.9B |
USD |
-51.5% |
Dec 31, 2023 |
Q4 2023 |
Preferred Stock, Shares Issued |
28.7M |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Deferred Federal Income Tax Expense (Benefit) |
331M |
USD |
|
Dec 31, 2023 |
Q4 2023 |
Current Income Tax Expense (Benefit) |
977M |
USD |
+89.7% |
Dec 31, 2023 |
Q4 2023 |
Unrecognized Tax Benefits |
19M |
USD |
+26.7% |
Dec 31, 2023 |
Q4 2023 |
Additional Paid in Capital |
15.2B |
USD |
+5.27% |
Mar 31, 2024 |
Q1 2024 |
Preferred Stock, Shares Outstanding |
28.7M |
shares |
|
Mar 31, 2024 |
Q1 2024 |
Current State and Local Tax Expense (Benefit) |
64M |
USD |
+8.48% |
Dec 31, 2023 |
Q4 2023 |
Current Federal Tax Expense (Benefit) |
809M |
USD |
+101% |
Dec 31, 2023 |
Q4 2023 |
Depreciation, Depletion and Amortization |
238M |
USD |
+44.2% |
Mar 31, 2024 |
Q1 2024 |
Share-based Payment Arrangement, Expense |
1.05B |
USD |
+105% |
Mar 31, 2024 |
Q1 2024 |
Deferred State and Local Income Tax Expense (Benefit) |
8M |
USD |
|
Dec 31, 2023 |
Q4 2023 |